Westminster Homecare has been acquired by Care at Home
The private shareholders of Westminster Homecare Ltd. have sold the company to Care at Home Services (South East) Ltd.
Westminster Homecare is a specialist provider of care services to the elderly and young adults. It operates a network of branches throughout London and the South of England delivering care services to over 3,500 service users, enabling them to remain independent in their homes for longer.
Care at Home is a privately owned, independent family business providing a range of care services to clients in their own homes, under several brands including Care at Home Services, Beech Tree Total Care, Domus Live-In Care, and now Westminster Homecare. Care at Home partnered with ThinCats, an alternative lender that provides loans to mid-sized UK businesses, to help fund the transaction.
Oaklins Evelyn Partners, based in the UK, worked with the shareholders of Westminster Homecare to deliver a successful sale to a strategic partner. Combined, the group will be one of the largest providers of homecare services, with over 3,700 staff operating from 28 branches delivering homecare to the community and also care in 18 extra care facilities.
Sushil Radia
CEO, Westminster Homecare Ltd.
Talk to the deal team
Brian Livingston
Oaklins Evelyn Partners
Related deals
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn moreCreo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Learn more